文献速递胸部肿瘤放疗

局部晚期非小细胞肺癌放疗时间与总生存的关系

Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-04-11

基于美国国家癌症数据库2004—2013年14154例接受根治性同步放化疗的III期NSCLC患者,44.2%存在放疗时间延长;延长者中位OS显著更差(18.6 vs 22.7个月,P<.0001),且每累积延迟区间生存逐步恶化;多因素分析显示放疗时间延长独立关联更差OS(HR 1.21,P<.0001)。

要点

  • 局部晚期NSCLC根治性同步放化疗中放疗时间延长与更差总生存独立相关。
  • 延迟累积越多生存越差,应尽量减少放疗中断。
  • 女性、黑人、非私人保险和低收入者更易出现放疗时间延长。

核心结论

  • 放疗期间延迟似乎对局部晚期NSCLC患者生存产生负面影响,应尽量减少累积中断。

研究设计与样本

  • 回顾性查询美国国家癌症数据库,纳入2004—2013年接受根治性同步化疗和分次放疗(59.4-70.0 Gy)的III期NSCLC患者14154例。
  • 按放疗剂量和分次数将放疗时间分为标准或延长,采用Cox比例风险模型评估与OS的关联。

主要发现

  • 14154例中6262例(44.2%)放疗时间延长。
  • 延长放疗时间者中位OS显著更差(18.6 vs 22.7个月,P<.0001)。
  • 随累积延迟区间增加OS逐步恶化:标准vs延长1-2天为20.5个月(P=.009),3-5天为17.9个月(P<.0001),6-9天为17.7个月(P<.0001),>9天为17.1个月(P<.0001)。
  • 多因素分析中延长放疗时间独立关联更差OS(HR 1.21,P<.0001);作为连续变量亦显著(HR 1.001,P=.0007)。
  • 与放疗时间延长相关的因素包括女性(OR 1.21,P<.0001)、黑人(OR 1.20,P=.001)、非私人保险(OR 1.30,P<.0001)和年收入低于63000美元(OR 1.20,P<.0001)。

临床怎么用

  • 对局部晚期NSCLC根治性同步放化疗患者,应尽量减少放疗累积中断以改善生存。
  • 关注女性、黑人、非私人保险和低收入患者,针对性解决导致放疗时间延长的障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prolonged radiation treatment (RT) time (RTT) has been associated with worse survival in several malignancies. The present study investigated whether delays during RT are associated with overall survival (OS) in non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: The National Cancer Database was queried for patients with stage III NSCLC who had received definitive concurrent chemotherapy and fractionated RT to standard doses (59.4-70.0 Gy) and fractionation from 2004 to 2013. The RTT was classified as standard or prolonged for each treatment regimen according to the radiation dose and number of fractions. Cox proportional hazards models were used to evaluate the association between the following factors and OS: RTT, RT fractionation, demographic and pathologic factors, and chemotherapeutic agents. RESULTS: Of 14,154 patients, the RTT was prolonged in 6262 (44.2%). Factors associated with prolonged RTT included female sex (odds ratio [OR] 1.21, P<.0001), black race (OR 1.20, P=.001), nonprivate health insurance (OR 1.30, P<.0001), and lower income (<$63,000 annually, OR 1.20, P<.0001). The median OS was significantly worse for patients with prolonged RTT than that for those with standard RTT (18.6 vs 22.7 months, P<.0001). Furthermore, the OS worsened with each cumulative interval of delay (standard RTT vs prolonged 1-2 days, 20.5 months, P=.009; prolonged 3-5 days, 17.9 months, P<.0001; prolonged 6-9 days, 17.7 months, P<.0001; prolonged >9 days, 17.1 months, P<.0001). On multivariable analysis, prolonged RTT was independently associated with inferior OS (hazard ratio 1.21, P<.0001). Prolonged RTT as a continuous variable was also significantly associated with worse OS (hazard ratio 1.001, P=.0007). CONCLUSIONS: Delays during RT appear to negatively affect survival for patients with locally advanced NSCLC. We have detailed the demographic and socioeconomic barriers influencing prolonged RTT as a method to address the health disparities in this regard. Cumulative interruptions of RT should be minimized.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. McMillan MT, Ojerholm E, Verma V, et al. Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721898. doi:10.1016/j.ijrobp.2017.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。